The Application of Propofol Combined with Remifentanil and LMA in Laparoscopic Ovarian Cystectomy

Abstract

Introduction: The application of Propofol combined with Remifentanil and Laryngeal Mask Airway (LMA) in laparoscopic ovarian cystectomy represents a significant advancement in the field of anesthetic techniques for minimally invasive gynecological surgeries. Aim of the study: The aim of this study was to evaluate the application of propofol combined with remifentanil and LMA in laparoscopic ovarian cystectomy. Methods: This cross-sectional study at North Bengal Medical Colleges and Bogura Medical College, Bangladesh from January 2015 - December 2018, included 120 female patients undergoing laparoscopic ovarian cystectomy. They were split into two groups of 60: Group A received remifentanil with propofol, and Group B received fentanyl with propofol for anesthesia, with LMA used in all cases. Result: There were no statistically significant difference (p>0.05) between the study groups in demographic characteristics. ASA grades I-III distributed comparably (p-values 0.6035 to 0.8529). Group-A had a shorter surgical time and less blood loss compared to Group-B. Hospital stay was shorter for Group-A than Group-B. Notably, Group-A showed significantly (p≤0.05) better anesthesia induction and recovery times, and higher OAAS scores, indicating quicker recovery. Group-A also reported significantly (p≤0.05) lower VAS scores for pain at various post-operation intervals, suggesting better pain management. Complications like nausea, pruritus, vomiting, and abdominal pain were slightly higher in Group-B, except for sore throat, which was equal in both groups. Conclusion: The use of propofol combined with remifentanil and Laryngeal Mask Airway for laparoscopic ovarian cystectomy has better anesthetic management, quicker recovery, more effective pain control, and fewer complications.